Summary
Generates process validation lifecycle narratives using FDA and ICH guidance, validation precedents, and statistical approaches for continued process verification.
Detailed Description
The Process Validation Narrative Pack supports sponsors in preparing process validation documentation aligned with the FDA's lifecycle approach to process validation. It compiles FDA guidance on process validation, ICH quality guidelines, and precedent validation strategies to help sponsors build comprehensive narratives for each validation stage.
The pack addresses all three stages of process validation: Stage 1 (Process Design), Stage 2 (Process Qualification), and Stage 3 (Continued Process Verification). It identifies critical process parameters and quality attributes requiring validation, recommends statistical approaches for establishing process capability, and provides precedent-based acceptance criteria.
Deliverables include a process validation master plan template, stage-specific validation narratives with statistical justifications, and a continued process verification strategy with control chart methodology recommendations.
Evidence Sources
| Source | Type | Description | Refresh |
|---|---|---|---|
| FDA Process Validation Guidance | REGULATORY | FDA guidance on process validation lifecycle including general principles and stage-specific requirements | Monthly |
| ICH Quality Guidelines | REGULATORY | ICH Q8, Q9, Q10, Q11, and Q12 guidelines on pharmaceutical development and quality management | Quarterly |
| Validation Precedent Database | CURATED | Curated database of process validation approaches from approved submissions with statistical methodologies | Quarterly |
Regulatory Mapping
Process Validation: General Principles and Practices
Pharmaceutical Development
Pharmaceutical Quality System
Agent Transparency
When you run this pack, your request is processed by a pipeline of specialized AI agents. Each agent operates with a defined confidence threshold and is auditable end-to-end.
Evidence Retriever
brew-retriever-v3
Queries curated sources for relevant evidence objects. Searches across regulatory databases, clinical registries, and scientific literature to surface the most pertinent references for the pack domain.
Domain Analyzer
brew-domain-analyst-v2
Applies domain-specific reasoning and regulatory mapping. Interprets evidence in the context of FDA, ICH, and EMA frameworks and tags each finding with the relevant guidance references.
Evidence Synthesizer
brew-synthesizer-v2
Synthesizes findings into structured output. Combines retrieved evidence and domain analysis into a cohesive narrative with quantitative summaries, comparative tables, and actionable recommendations.
Output Validator
brew-validator-v1
Validates citations, checks confidence thresholds, and ensures all referenced sources are accessible and correctly attributed. Flags any claims that fall below the confidence floor.
Sample Outputs
Process Validation Master Plan
DOCXMaster plan template covering all three validation stages with scope, strategy, and acceptance criteria
Stage-Specific Validation Narratives
PDFDetailed narratives for each validation stage with statistical justifications and precedent alignment
Continued Process Verification Strategy
PDFCPV strategy with control chart methodology, sampling plans, and trend analysis approaches
Deliverables included
- Process validation master plan template
- Stage 1 (Process Design) narrative
- Stage 2 (Process Qualification) protocol recommendations
- Stage 3 (Continued Process Verification) strategy
- Statistical methodology justification document
Related Disease & Biomarker Mappings
| Therapeutic Area | Disease Family | Key Biomarkers | Relevance |
|---|---|---|---|
| Biologics Manufacturing | Monoclonal Antibodies | Glycosylation ProfileCharge VariantsHCP Levels | Primary |
| Gene Therapy | AAV-Based Therapies | Vector Genome TiterCapsid IntegrityPotency Assay | Secondary |
Related Packs in CMC & Quality
Excipient Justification Pack
Justify every excipient with regulatory-grade evidence
Comparability Strategy Pack
Navigate manufacturing changes without derailing your program
Advanced Manufacturing Pack
Regulatory intelligence for next-generation manufacturing
Version History
Current release — expanded evidence sources, improved citation accuracy, and added new regulatory cross-references.
Beta release — validated with domain SMEs. Added sample output previews and refined confidence scoring.
Initial draft — core evidence retrieval pipeline and output schema established.
Need a Custom Evidence Pack?
Our enterprise team can build bespoke evidence packs tailored to your therapeutic area, regulatory strategy, or internal decision framework. Custom packs include dedicated evidence source curation, domain-specific agent tuning, and priority SLA support.
Enterprise packs are available for organizations on the BrewBio Pro or Enterprise plan.